blog_type:product

INNOTOX: What It Is, and How to Source It Authentically

July 03, 2026Editor J.S
INNOTOX: What It Is, and How to Source It Authentically

INNOTOX is Medytox's botulinum toxin type A, a prescription-only injectable licensed in Korea on 11 December 2013 and supplied as a ready-to-use liquid rather than a powder. It is one of the three Korean toxins a sourcing buyer meets first, alongside Nabota and Botulax, and the only one of the three that comes as a liquid. This profile covers what INNOTOX is, how it appears in the Korean drug register, where it sits among the Korean options, and how to verify that a specific vial is genuine.

It sits in the botulinum toxin category, and like everything KSTATION publishes about a specific product, it stays in the lane a distributor can stand behind: what INNOTOX is, how it is regulated, and how to verify it. It does not describe how to use it or what results to expect, which are clinical questions for a trained professional.

What INNOTOX is

INNOTOX is a botulinum toxin type A produced by Medytox, a South Korean manufacturer. It is a prescription product intended for administration by trained professionals, not a consumer cosmetic. As a botulinum toxin, it is regulated as a drug rather than a cosmetic in every market that regulates it.

The INNOTOX liquid formulation

The spec that distinguishes INNOTOX from most botulinum toxins is its format. Where most toxins ship as a lyophilized powder that must be reconstituted before use, INNOTOX is supplied by the manufacturer as a ready-to-use liquid. That is the neutral, verifiable difference to read on the label, and it is the reason the product is discussed as a distinct option rather than as interchangeable with powder toxins.

INNOTOX in the Korean drug register

In the Korean drug register INNOTOX is a single filing, 이노톡스주, held by Medytox Inc. ((주)메디톡스) and granted on 11 December 2013. It is a prescription-only medicine, its status is live, and it names no contract manufacturer, so the licence holder on file is also the maker on file. The export name recorded on the filing is INNOTOX Inj.

That one filing covers three vial sizes. The register lists the packs as one vial per box at 25 units in 0.625 mL, 50 units in 1.25 mL and 100 units in 2.5 mL, the same strength in three fill volumes. This is a different structure from the other two main Korean toxins: Nabota is four filings, one per vial size, as set out in our Nabota profile, and Botulax is five. For INNOTOX the filing is the same whichever size is inside, so the size printed on the carton is what separates one presentation from another.

INNOTOX in the Korean drug register (MFDS open data), read on 5 November 2026. One filing, 이노톡스주, held by Medytox Inc., covering three pack sizes.
Units per vial Fill volume Pack Stocked by KSTATION
25 0.625 mL 1 vial per box No
50 1.25 mL 1 vial per box Yes
100 2.5 mL 1 vial per box Yes

Two more fields are useful at the point of checking a vial. The register describes the product as a colourless, clear liquid in a colourless, clear vial, which matches the liquid format above; the Nabota and Botulax filings describe a dried powder. It also records six barcodes for the filing, two for each of the three sizes. The listed inactive ingredients are sodium chloride, polysorbate 20, L-methionine and water for injection.

INNOTOX among the Korean toxins

INNOTOX is one of several botulinum toxin type A products made in South Korea, and buyers often weigh it against Nabota and Botulax. The neutral, checkable way to place them side by side is by manufacturer and formulation, not by claimed effect. The formulation row is the one that actually sets INNOTOX apart.

Korean botulinum toxin type A, at a glance
Product Manufacturer Formulation
INNOTOX Medytox Liquid, ready-to-use
Nabota Daewoong Vacuum-dried powder
Botulax Hugel Lyophilized powder

All three are prescription products for professional use and regulated as drugs. Their approval status differs by country and by product, so confirm the specific product and market rather than assuming they share a status.

INNOTOX regulatory status by market

Status differs by country and belongs on any honest profile. INNOTOX is approved and marketed as a drug in South Korea under the Ministry of Food and Drug Safety (MFDS). In the United States, INNOTOX is not FDA-approved. Two other Korean-made type A toxins are: Daewoong's, approved in 2019 and sold there as Jeuveau, and Hugel's, approved in 2024 as Letybo.56 A US approval belongs to the specific product named in it, so neither one extends to INNOTOX. Anything intended to affect the structure or a function of the body is regulated as a drug, not a cosmetic, so confirm current status with the relevant authority before acting.

How to verify authentic INNOTOX

Because a botulinum toxin's value and safety depend on it being the genuine, correctly handled product, verification is the part that actually matters when sourcing. Counterfeits and parallel-imported stock are a real risk in this category, which is exactly why the checklist below is the same discipline that runs through every KSTATION profile.

  • Official channel. Buy through an authorized route, not an anonymous reseller, so provenance is traceable back to the manufacturer.
  • Manufacturer and format. Confirm the maker (Medytox) and the exact presentation match the listing. INNOTOX is a ready-to-use liquid, so a powder sold as INNOTOX, or the liquid format attributed to a powder-only brand, is a contradiction worth stopping on.
  • Serialization and codes. Genuine Korean prescription packaging carries a GS1 DataMatrix code that encodes the product identifier, serial number, lot, and expiry under Korea's MFDS serialization system, and the lot and expiry should match exactly between vial and carton.
  • Regulatory marks and seal. Look for MFDS approval and KGMP manufacturing marks, an intact tamper-evident holographic seal, and clean, correct printing on the carton.
  • Cold chain. Confirm temperature-controlled handling at 2 to 8 degrees Celsius was maintained end to end, since toxins are temperature-sensitive biologics that can degrade even when the unit is genuine.
  • Stop signals. Treat missing provenance, unusual pricing, or an untraceable origin as reasons to stop, not to negotiate.

That is the short form of the check. For the full counterfeit-spotting method, including the exact carton markings the FDA flagged in the 2024 counterfeit case, see how to verify an authentic Korean botulinum toxin.

Where INNOTOX sourcing fits

From a sourcing standpoint, an authentic toxin and a traceable supply chain are the same thing. KSTATION carries INNOTOX in 50-unit and 100-unit presentations through official channels (the 25 unit vial in the same filing is not part of our range), alongside the wider botulinum toxins range, intended for professional use. Our verification method is set out in the Editorial & Sourcing Policy.

Frequently asked questions

Frequently asked

Is INNOTOX FDA-approved?

No. INNOTOX is approved as a drug in South Korea by the MFDS and is not FDA-approved in the United States. Two other Korean toxins are, Jeuveau (Daewoong) since 2019 and Letybo (Hugel) since 2024, and neither approval covers INNOTOX. Confirm current status with the relevant authority.

What makes INNOTOX different from other botulinum toxins?

Its format. INNOTOX is supplied by Medytox as a ready-to-use liquid, whereas most botulinum toxins, including Nabota and Botulax, are a dried powder that must be reconstituted before use (Nabota vacuum-dried, Botulax freeze-dried). That is the neutral, checkable distinction; anything beyond it is a clinical question.

How does INNOTOX compare to Nabota and Botulax?

All three are botulinum toxin type A products for professional use, and the neutral, checkable difference is manufacturer and formulation. INNOTOX is a ready-to-use liquid from Medytox, whereas Nabota (Daewoong, vacuum-dried) and Botulax (Hugel, freeze-dried) are dried powders that must be reconstituted before use. Approval status differs by country and product, so confirm the specific product and market rather than assuming a shared status.

Who makes INNOTOX, and in which country?

Medytox Inc., a South Korean company. It holds the Korean licence for INNOTOX, and the filing names no contract manufacturer, so the licence holder is also the maker on record.

What sizes is INNOTOX licensed in?

Three, all under one Korean filing: 25 units in 0.625 mL, 50 units in 1.25 mL and 100 units in 2.5 mL, each packed one vial per box. KSTATION stocks the 50 and 100 unit vials.

How do I verify authentic INNOTOX?

Source through an official channel with traceable provenance, confirm the manufacturer and exact presentation match the listing, check the packaging seal and any GS1 DataMatrix or verification codes, match the lot and expiry between vial and carton, and confirm cold-chain handling was maintained. Untraceable origin or unusual pricing are reasons to stop.

Disclaimer. This article is general educational information and is not medical advice. INNOTOX is a prescription botulinum toxin for administration by trained professionals; this profile does not describe dosing, administration, or expected results. Regulatory status varies by country and changes over time; confirm current requirements with the relevant authority.

Sources & references

  1. Medytox, manufacturer of INNOTOX (corporate information). medytox.com
  2. U.S. FDA, Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?), structure/function vs. drug regulation. fda.gov
  3. GS1 / MFDS, pharmaceutical serialization and traceability system in South Korea (GS1 DataMatrix encoding product identifier, serial, lot, expiry). gs1.org
  4. U.S. FDA, Counterfeit Version of Botox Found in Multiple States (counterfeit carton markings and unlicensed-source risk). fda.gov
  5. U.S. FDA approval of Jeuveau (prabotulinumtoxinA-xvfs), Evolus, 2019, for temporary improvement of glabellar lines. accessdata.fda.gov
  6. U.S. Food and Drug Administration, Drug Trials Snapshots: LETYBO (letibotulinumtoxinA; FDA approval February 29, 2024). fda.gov
  7. Ministry of Food and Drug Safety (MFDS), drug product licence register (open data service), filing 이노톡스주, fields for licence holder, contract manufacturer, grant date, status, description, pack units, barcodes and inactive ingredients, retrieved 5 November 2026.

Curated for this read

Shop related

Browse the range

Explore the collection

KSTATION Editorial

K-beauty, decoded. Weekly.

Three reads a week on ingredients, treatments, and sourcing. One short digest every Sunday. Sourcing-side clarity, no hype.

Unsubscribe anytime. We never share your email.

More from KSTATION

Related Articles